Gastroenterology[jour] AND 2024/9/10[edat] - Search Results

1

Rezaie A, Yeo YH. Rezaie A, et al. Gastroenterology. 2024 Sep 7:S0016-5085(24)05449-0. doi: 10.1053/j.gastro.2024.09.002. Online ahead of print. Gastroenterology. 2024. PMID: 39251164 No abstract available.

2

Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities.

Gupta V, Sehrawat TS, Pinzani M, Strazzabosco M. Gupta V, et al. Gastroenterology. 2024 Sep 7:S0016-5085(24)05455-6. doi: 10.1053/j.gastro.2024.07.044. Online ahead of print. Gastroenterology. 2024. PMID: 39251168 Review.

3

Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis.

Roshanov PS, Khanna R. Roshanov PS, et al. Gastroenterology. 2024 Sep 7:S0016-5085(24)05444-1. doi: 10.1053/j.gastro.2024.08.035. Online ahead of print. Gastroenterology. 2024. PMID: 39251167 No abstract available.

4

Incidence and risk factors for colorectal cancer in Africa: a systematic review and meta-analysis.

Tazinkeng NN, Pearlstein EF, Manda-Mapalo M, Adekunle AD, Monteiro JFG, Sawyer K, Egboh SC, Bains K, Chukwudike ES, Mohamed MF, Asante C, Ssempiira J, Asombang AW. Tazinkeng NN, et al. BMC Gastroenterol. 2024 Sep 9;24(1):303. doi: 10.1186/s12876-024-03385-7. BMC Gastroenterol. 2024. PMID: 39251919 Free PMC article.

5

Genetic estimation of causalities between educational attainment with common digestive tract diseases and the mediating pathways.

Wang Y, Bi Y, Wang Y, Ji F, Zhang L. Wang Y, et al. BMC Gastroenterol. 2024 Sep 9;24(1):304. doi: 10.1186/s12876-024-03400-x. BMC Gastroenterol. 2024. PMID: 39251923 Free PMC article.

6

A Head-to Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn's Disease.

Roshanov PS, Khanna R. Roshanov PS, et al. Gastroenterology. 2024 Sep 7:S0016-5085(24)05445-3. doi: 10.1053/j.gastro.2024.08.036. Online ahead of print. Gastroenterology. 2024. PMID: 39251166 No abstract available.

7

Proteomic Biomarkers in Serum Predict Villous Atrophy Development in Asymptomatic Potential Celiac Disease Children at Time of Diagnosis.

Auricchio R, Mandile R, Samsom J, Esposito C, de Cegli R, Greco L; European Laboratory for Food Induced Disease (ELFID) Group. Auricchio R, et al. Gastroenterology. 2024 Sep 7:S0016-5085(24)05446-5. doi: 10.1053/j.gastro.2024.09.001. Online ahead of print. Gastroenterology. 2024. PMID: 39251165 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page